NCT00004779View on ClinicalTrials.gov

Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 1993

Conditions
Cystic Fibrosis
Interventions
GENETIC

Ad5-CB-CFTR

All Listed Sponsors
collaborator

University of North Carolina

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004779 - Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter